We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
I am the Head of the Division of Solid Tumor Oncology in Memorial Sloan Kettering Cancer Center’s Department of Medicine. I am also a medical oncologist who cares for people with advanced colon cancer and pancreatic cancer and a researcher applying cancer genetics to find new ways to diagnose and treat the disease.
Read more
My research focuses on applied cancer genetics. The more we learn about a tumor’s makeup, the more precise targets and diagnostics we can create against it — including immunotherapy treatments, which harness the body’s immune system to fight cancer. I am also very interested in how we can use cancer genetics to screen for, detect, diagnose, and monitor cancer by looking at DNA in tumor tissue and by using liquid biopsies.
With my colleagues, I am working to develop a “molecular pap smear” that is able to diagnose early-stage ovarian cancer and endometrial cancer based on these genetic markers — a crucial advance that would mean we could catch more instances of these cancers and begin treating them as quickly as possible. The test is currently in clinical trials. My hope is that we will start seeing this as part of the standard of care within the next few years.
As part of my role as Head of Solid Tumor Oncology, I am also working to improve mentorship for our young scientists and communication between researchers and departments across MSK. I am also involved in projects to improve our patients’ experience as well as their access to our unmatched cancer care.
I strive to support my patients at every step of the way throughout their treatment. The patients I see are often facing a lethal diagnosis. It’s important that they feel as though, along with the rest of their treatment team, we’re all in this together.
My Role at MSK
A gastrointestinal (GAS-troh-in-TES-tih-nul) oncologist is a cancer doctor with special training in the gastrointestinal (GI) system. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
Areas of Expertise
My Specialties
Colorectal Cancer
Pancreatic Cancer
Bile Duct Cancer
Neuroendocrine Tumors of the GI Tract
Education & Honors
Education
MD, University of Michigan
Residencies
The Johns Hopkins School of Medicine
Awards and Honors
Elected Member, National Academy of Medicine (2023)
AACR Team Science Award (2013, 2014, 2017)
Fellowships
The Johns Hopkins School of Medicine
Board Certifications
Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Visit PubMed for a full listing of Dr. Diaz Jr.’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Luis Diaz Jr. discloses the following relationships and financial interests:
ChromaCode Equity
Delfi Diagnostics, Inc. Equity; Professional Services and Activities (Uncompensated)
Epitope Equity; Fiduciary Role / Position
Exact Sciences Corporation Equity
Innovatus Capital Partners, LLC Professional Services and Activities
Johns Hopkins University School of Medicine Intellectual Property Rights
Jounce Therapeutics Equity
Kinnate Biopharma Inc. Equity; Professional Services and Activities
LabCorp Equity
Neophore Equity; Professional Services and Activities (Uncompensated)
Personal Genome Diagnostics Equity
Quest Diagnostics Equity; Fiduciary Role / Position
Seer Biosciences Equity; Professional Services and Activities
Thrive Equity
Zydecom Equity
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
